Trials / Not Yet Recruiting
Not Yet RecruitingNCT06662604
Using of Bone Marrow Stem Cell Concentrate with Platelet Rich Fibrin and Bone Graft in Bone Reconstruction of Upper Jaw Bony Cystic Defects, Comparing with Platelet Rich Fibrin with Bone Graft
Evaluation of Bone Marrow Stem Cells Concentrate with Platelet Rich Fibrin and Bone Graft in Bone Regeneration of Maxillary Cystic Defects Versus Platelet Rich Fibrin with Bone Graft (a Randomized Controlled Trial)
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 22 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Will the use of bone marrow stem cells with platelet rich fibrin enhance and accelerate the bone regeneration in the upper jaw cystic defects ?
Detailed description
Reconstruction of critical size bone defect in maxillofacial surgery is a great challenge, current practice of bone reconstruction still having problems like delay in bone regeneration (up to 12 months) and bone graft failure and low availability of autogenous bone graft. last decade stem cells therapy gained great interest, in many studies Bone marrow stem cells showed promising result in bone regeneration enhancing . Platelet Rich Fibrin PRF also capability of enhancing bone and tissue regeneration by releasing of certain protein molecules call growth factors that initiate sequential biological events resulting in stem cells migration into the site of bone defect and differentiation to bone formation cells (osteoblast cells ).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Bone marrow stem cells concentrate , platelet rich fibrin , bone graft | All participants will be treated with Bone marrow stem cells concentrate , platelet rich fibrin , bone graft. |
| BIOLOGICAL | platelet rich fibrin and bone graft | All participants will treated with platelet rich fibrin PRF , bone graft. |
Timeline
- Start date
- 2024-10-26
- Primary completion
- 2025-09-17
- Completion
- 2026-02-22
- First posted
- 2024-10-29
- Last updated
- 2024-10-29
Source: ClinicalTrials.gov record NCT06662604. Inclusion in this directory is not an endorsement.